1. Home
  2. HNVR vs BDTX Comparison

HNVR vs BDTX Comparison

Compare HNVR & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hanover Bancorp Inc.

HNVR

Hanover Bancorp Inc.

HOLD

Current Price

$23.73

Market Cap

153.5M

Sector

Finance

ML Signal

HOLD

Logo Black Diamond Therapeutics Inc.

BDTX

Black Diamond Therapeutics Inc.

HOLD

Current Price

$1.84

Market Cap

171.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HNVR
BDTX
Founded
2008
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
153.5M
171.9M
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
HNVR
BDTX
Price
$23.73
$1.84
Analyst Decision
Buy
Strong Buy
Analyst Count
2
7
Target Price
$24.50
$9.67
AVG Volume (30 Days)
73.2K
1.9M
Earning Date
04-27-2026
05-08-2026
Dividend Yield
1.72%
N/A
EPS Growth
N/A
130.71
EPS
0.25
N/A
Revenue
N/A
N/A
Revenue This Year
$35.49
N/A
Revenue Next Year
$8.61
N/A
P/E Ratio
$93.28
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.91
$1.60
52 Week High
$24.55
$4.94

Technical Indicators

Market Signals
Indicator
HNVR
BDTX
Relative Strength Index (RSI) 56.78 45.28
Support Level $21.89 $1.60
Resistance Level $24.34 $2.30
Average True Range (ATR) 0.77 0.14
MACD -0.02 0.05
Stochastic Oscillator 60.00 68.02

Price Performance

Historical Comparison
HNVR
BDTX

About HNVR Hanover Bancorp Inc.

Hanover Bancorp Inc is a community commercial bank focused on providing personalized and efficient services and products tailored to local needs. The Bank offers a full range of financial services, including a complete suite of consumer, commercial, and municipal banking products such as multifamily and commercial mortgages, government-guaranteed loans, residential loans, business loans, and lines of credit. In addition, it provides customers with access to 24-hour ATM services with no fees, interest-bearing free checking accounts, telephone banking, mobile and internet banking solutions for both consumer and business clients, and safe deposit boxes.

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The foundation of companies has been built upon a deep understanding of cancer genetics, onco-protein structure and function, and medicinal chemistry. Its clinical-stage program, silevertinib (formerly BDTX-1535), a brain-penetrant, fourth-generation epidermal growth factor receptor (EGFR) MasterKey inhibitor, is currently being studied in a Phase 2 clinical trial in patients with epidermal growth factor receptor mutant (EGFRm) non-small cell lung cancer (NSCLC). The Company manages its operations as a single operating segment and single reportable segment.

Share on Social Networks: